Jefferies Financial Group Inc.
Position in DNTH — Dianthus Therapeutics, Inc. /DE/
CIK 96223
NEW YORK, NY
Position in DNTH
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$16,986,247
+$16,758,247 QoQ
Shares Held
202,410
+2563.3% QoQ
Ownership
0.370%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DNTH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Jefferies Financial Group Inc. holds $507,365,833 across 84 Biotechnology names. DNTH ranks #8 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTCT |
Ptc Therapeutics, Inc.
|
1,354,459 | $92,279,291 | |
| 2 | IMTX |
Immatics N.V.
|
5,059,551 | $49,785,981 | |
| 3 | URGN |
UroGen Pharma Ltd.
|
2,199,652 | $39,549,742 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
175,599 | $33,196,990 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
468,146 | $26,445,567 | |
| 6 | IMNM |
Immunome Inc.
|
1,160,715 | $25,384,837 | |
| 7 | ARGX |
Argenx SE
|
30,005 | $21,911,151 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
This page
|
202,410 | $16,986,247 |
All Filings in DNTH
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,986,247 | 202,410 | Shares | Defined | 2026-05-08 | |
| 2024-03-31 | $228,000 | 7,600 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $137,280 | 13,200 | Shares | Defined | 2024-05-06 | |
| 2023-09-30 | $180,444 | 13,200 | Shares | Defined | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||